How collaboration will strengthen the future of cell and gene therapies
As clinical science continues to deliver on the promise of CGT, how can the industry make them available and affordable at scale?
Close log in window
Closer relationships with patients and a better understanding of what matters to them will show the way improving their experience of trials
There is a golden opportunity to deliver clinical trial innovation post-pandemic given healthcare’s appetite for new approaches, such as v...
The impacts of 2020 on trials are causing pharma to consider a new direction for trial sites, taking them closer to the patient
Broader and deeper outreach, along with RWE, are some of the methods pharma is using to widen trials participation
